Rafferty Asset Management
OLMA icon

Rafferty Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

Rafferty Asset Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.96M Buy
131,520
+86,515
+192% +$1.93M 0.01% 616
2025
Q4 		$1.13M Buy
+45,005
New +$801K ﹤0.01% 774
2025
Q1 		– Sell
-81,424
Closed -$475K – 1128
2024
Q4 		$475K Sell
81,424
-9,051
-10% -$90.4K ﹤0.01% 923
2024
Q3 		$1.08M Sell
90,475
-11,531
-11% -$147K ﹤0.01% 785
2024
Q2 		$1.1M Sell
102,006
-192,713
-65% -$2.09M ﹤0.01% 794
2024
Q1 		$3.34M Buy
+294,719
New +$3.8M 0.01% 552

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Rafferty Asset Management's OLMA Position: Q1 2026 in Review

Rafferty Asset Management increased its Olema Pharmaceuticals (OLMA) stake by 192% in Q1 2026, buying an estimated $1.93M and bringing the position to 131,520 shares worth $1.96M. The position accounts for 0.01% of the portfolio, ranked #616.

Rafferty Asset Management first reported a position in OLMA in Q1 2024 and has held it in 6 quarters since. The position peaked at $3.34M in Q1 2024. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Rafferty Asset Management held 131,520 shares of Olema Pharmaceuticals worth $1.96M as of Q1 2026.
  • Rafferty Asset Management bought 86,515 Olema Pharmaceuticals shares in Q1 2026, an estimated $1.93M.
  • Olema Pharmaceuticals made up 0.01% of Rafferty Asset Management's portfolio in Q1 2026, its #616 holding.
  • Rafferty Asset Management first reported a position in Olema Pharmaceuticals in Q1 2024 and has held it in 6 quarters since.
  • Rafferty Asset Management's Olema Pharmaceuticals position peaked at $3.34M in Q1 2024.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.